UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014770
Receipt number R000017167
Scientific Title The expression of the sex steroids receptor and serum sex steroids status in uterine fibroids, endometriosis, and uterine adnomyosis
Date of disclosure of the study information 2014/08/06
Last modified on 2014/08/05 23:39:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The expression of the sex steroids receptor and serum sex steroids status in uterine fibroids, endometriosis, and uterine adnomyosis

Acronym

The sex steroids receptor expression in fibroids, endometriosis, and adnomyosis.

Scientific Title

The expression of the sex steroids receptor and serum sex steroids status in uterine fibroids, endometriosis, and uterine adnomyosis

Scientific Title:Acronym

The sex steroids receptor expression in fibroids, endometriosis, and adnomyosis.

Region

Japan


Condition

Condition

uterine fibroma, endometriosis, uterine adenomyosis

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate of the role of the expression of sex steroids receptors and serum steroids levels between fibroma, endometriosis, and adenomyosis.

Basic objectives2

Others

Basic objectives -Others

retrospectively evaluation of pathogenesis

Trial characteristics_1

Others

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

the quantification of expression levels of sex steroids receptors in legions obtained from specimens, and comparison of serum levels of sex steroids between diseases.

Key secondary outcomes



Base

Study type


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

no prior treatments

Interventions/Control_2

progestin therapy

Interventions/Control_3

GnRHa therapy

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Female

Key inclusion criteria

the patients with uetrine fibroma,who have received surgical treatments

Key exclusion criteria

under 20 years old, over 40, or post menopausal women

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahide Ohmichi

Organization

Osaka Medical College

Division name

Obstetrics and Gynecology

Zip code


Address

2-7 Daigaku-machi, Takatsuki city, Osaka, Japan

TEL

+81-72-683-1221

Email

gyn74@poh.osaka-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atushi Hayashi

Organization

Osaka Medical College

Division name

Obstetrics and Gynecology

Zip code


Address

2-7 Daigaku-machi, Takatsuki city, Osaka, Japan

TEL

+81-72-683-1221

Homepage URL


Email

gyn74@poh.osaka-med.ac.jp


Sponsor or person

Institute

Dept of Obstetrics and Gynececology, Osaka medical college.

Institute

Department

Personal name



Funding Source

Organization

KAKENHI

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪医科大学(大阪府)


Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 17 Day

Date of IRB


Anticipated trial start date

2011 Year 01 Month 18 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 05 Month 31 Day

Date trial data considered complete

2014 Year 05 Month 31 Day

Date analysis concluded

2014 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 08 Month 05 Day

Last modified on

2014 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017167


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name